Nadifex 180 USP tablets reduce allergic rhinitis, sneeze, nose (1 blister x 10 tablets)
Dosage form Box of 1 blister x 10 tablets
Specifications Fexofenadin HCl
Ingredient
Thành phần cho 1 viên
| Composition information | Content |
| Fexofenadin HCl | 180mg |
Uses
indications
Nadifex 180 drug is indicated to use tron: mitigate the symptoms that come with allergic rhinitis allergies such as sneezing, nasal nose, nasal congestion, surround itch/throat/throat.
Pharmacokic
Fexofenadin is an antihistamine H1, which does not cause drowsiness. Fexofenadin is a pharmacological activity of terfenadin . Fexofenadin inhibits histamine release from mast cells. Both fiber optical isomers of fexofenadine have the same antihistamine effect. The drug does not pass the bloodstream barrier.
Pharmacokinetics
absorption
Fexofenadin is quickly absorbed into the body after drinking. The drug reaches the peak concentration after taking about 1-3 hours. The average peak concentration is about 494 ng/ml after use 180 mg/time per day.
Distribution
Fexofenadin binds to plasma proteins about 60 - 70%.
Metabolism
Fexofenadin metabolizes negligible (drugs metabolized through the liver about 5% of the total dose).
Elimination
The main excretion path is thought to be excreted through bile, 10% of oral doses are eliminated in the form of unchanged urine.
Before taking Nadifex 180 USP tablets reduce allergic rhinitis, sneeze, nose (1 blister x 10 tablets)
How to use
Take oral water with water, take medicine when hungry.
Dosage
Dosage and medication time for each specific case depending on the prescription of the treating doctor.
Normal dose:
Adults and children over 12 years: 1 tablet 180 mg x 1 time/day.
Not for kidney failure.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when using overdose?
Handling: Using conventional measures to eliminate hemolysis drugs that reduce the concentration of drugs in the blood (1.7%). There is no specific antidote.
What to do when you forget 1 dose? Ignore any of the forgotten dose if it is close to the next dose. Do not use two doses at the same time.
Side Effects
In control clinical studies, the unwanted effect rate in the patient group using fexofenadin is similar to the Placebo. The unwanted effects of the drug are not affected by the dosage, age, gender and race of the patient. When using Nadifex 180, you may experience unwanted effects (ADR).
Common, ADR> 1/100
Other: viral infection (colds, influenza ), dysmenorrhea, upper respiratory infection, itchy throat, fever, cough, otitis media , sinusitis, lung.
Uncommon, 1/1000 Rare, ADR Instructions on how to handle ADR The unwanted effects of the drug are usually mild, only 2.2% of patients have to stop the drug due to the unwanted effects of the drug. Notify the doctor with unwanted effects when using the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Nadifex 180 contraindicated drug in the following cases:
Be cautious when using
Fexofenadin should be used cautiously in elderly people, patients with renal impairment or liver failure.
The ability to drive and operate machinery
The drug is less likely to cause drowsiness, but still need to be cautious when operating machinery or driving train.
Pregnancy
There is no full range of controlled studies on pregnant women. Fexofenadin should only be used for pregnant women when they have considered the benefits and risks for the child.
The period of breastfeeding
There has been no notice that fexofenadin secreted through breast milk. There is no sufficient research on breastfeeding women, so be careful when indicating fexofenadin for breastfeeding women.
Interactive drug
Because the drug can reduce the effect of antacids containing aluminum and magnesi, the drug should be used for about 2 hours apart.
Storage
Store drugs in a dry place, temperatures below 30 ° C, avoiding light.
To be out of reach of children.
Other drugs
- Amgevita
- BUSCOPAN AMPOULES 20MG/ML
- FLUCLOXACILLIN 250MG CAPSULES
- LIPOSIC EYE GEL 2MG/G EYE GEL
- Nimenrix
- Tolura
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions